Business · 14/02/2023Updated: 10/17/2026 · 1 min read
FDA Submits Collection of Information for OMB Review
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on medical device labeling requirements and unique device identification, as part of the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →